Safety and tolerability of quizartinib, a FLT3 inhibitor, in advanced solid tumors: a phase 1 dose-escalation trial
Papadopoulos, Kyriakos P., Ben-Ami, Eytan, Patnaik, Amita, Trone, Denise, Li, Jianke, Demetri, George D.Volume:
18
Language:
english
Journal:
BMC Cancer
DOI:
10.1186/s12885-018-4692-z
Date:
December, 2018
File:
PDF, 704 KB
english, 2018